Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
Clinical trial NCT00293111 · TERMINATED
Trial details
- NCT number
- NCT00293111
- Sponsor
- Cephalon
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2003-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.